Skip to main content

Table 1 Consumption levels of prescription opioids, non-medical prescription opioid use, prescription opioid-related morbidity and prescription opioid-related mortality measures in the United States from 2001 – 2010

From: Harms of prescription opioid use in the United States

Year

S-DDD

NMPOU prevalence (past month)

NMPOU prevalence (past year)

NMPOU prevalence (lifetime)

Average number of days per year per person of NMPOU (general population)

Average number of days per year per person of NMPOU (NMPOU users)

Substance abuse treatment admissions for POs per 10,000 people

PO overdose deaths per 100,000 people

2001

22,524

1.5%

3.7%

9.8%

1.61

43.93

1.31

1.92

2002

25,993

1.9%

4.7%

12.8%

1.91

40.55

1.58

2.57

2003

29,500

2.0%

5.0%

13.2%

1.92

38.33

1.81

2.90

2004

33,532

1.8%

4.7%

13.4%

1.85

39.46

2.08

3.33

2005

37,565

1.9%

4.8%

13.5%

1.95

40.69

2.38

3.65

2006

40,604

2.0%

5.0%

13.5%

2.16

43.23

2.75

4.54

2007

42,230

2.1%

5.1%

13.4%

2.37

46.53

3.23

4.67

2008

45,054

1.9%

4.8%

14.1%

2.15

44.79

3.96

4.79

2009

47,809

2.1%

5.0%

14.2%

2.52

50.32

4.60

5.00

2010

51,081

2.1%

4.9%

13.7%

2.37

48.31

-

5.29

  1. S-DDD: Defined daily doses for statistical purposes per million inhabitants per day.
  2. NMPOU: Non-medical prescription opioid use.
  3. PO: Prescription opioid.